Northern Trust Corp Taro Pharmaceutical Industries LTD Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$40.97 - $43.33 $306,332 - $323,978	-7,477 Reduced 12.04%	54,603 $2.31 Million
Q4 2023 Feb 13, 2024	BUY	$32.77 - $42.31 $135,635 - $175,121	4,139 Added 7.14%	62,080 $2.59 Million
Q3 2023 Nov 13, 2023	BUY	$35.46 - $40.13 $18,651 - $21,108	526 Added 0.92%	57,941 $2.18 Million
Q2 2023 Aug 11, 2023	BUY	$24.24 - $40.97 $1.39 Million - $2.35 Million	57,415 New	57,415 $2.18 Million
Q2 2022 Aug 12, 2022	SELL	$35.0 - $43.59 $336,105 - $418,594	-9,603 Reduced 45.87%	11,334 $409,000
Q1 2022 May 13, 2022	SELL	$43.12 - $50.3 $2.21 Million - $2.58 Million	-51,344 Reduced 71.03%	20,937 $906,000
Q4 2021 Feb 08, 2022	SELL	$47.6 - $65.0 $61,499 - $83,980	-1,292 Reduced 1.76%	72,281 $3.62 Million
Q3 2021 Nov 15, 2021	SELL	$62.34 - $73.38 $1.26 Million - $1.48 Million	-20,137 Reduced 21.49%	73,573 $4.68 Million
Q2 2021 Aug 13, 2021	SELL	$70.26 - $76.64 $354,531 - $386,725	-5,046 Reduced 5.11%	93,710 $6.74 Million
Q1 2021 May 12, 2021	SELL	$70.48 - $79.95 $7.03 Million - $7.98 Million	-99,783 Reduced 50.26%	98,756 $7.28 Million
Q4 2020 Feb 11, 2021	BUY	$54.4 - $73.42 $382,268 - $515,922	7,027 Added 3.67%	198,539 $14.6 Million
Q3 2020 Nov 16, 2020	BUY	$54.41 - $68.2 $3.31 Million - $4.15 Million	60,814 Added 46.53%	191,512 $10.5 Million
Q2 2020 Aug 14, 2020	BUY	$61.66 - $70.16 $4.28 Million - $4.87 Million	69,439 Added 113.35%	130,698 $8.69 Million
Q1 2020 May 14, 2020	SELL	$59.35 - $88.73 $10,623 - $15,882	-179 Reduced 0.29%	61,259 $3.75 Million
Q4 2019 Feb 14, 2020	BUY	$74.18 - $97.92 $264,154 - $348,693	3,561 Added 6.15%	61,438 $5.4 Million
Q3 2019 Nov 13, 2019	BUY	$75.36 - $86.57 $352,157 - $404,541	4,673 Added 8.78%	57,877 $4.37 Million
Q2 2019 Aug 13, 2019	SELL	$83.92 - $108.88 $34,239 - $44,423	-408 Reduced 0.76%	53,204 $4.55 Million
Q1 2019 May 13, 2019	SELL	$85.97 - $108.09 $446,184 - $560,987	-5,190 Reduced 8.83%	53,612 $5.79 Million
Q4 2018 Feb 12, 2019	SELL	$78.25 - $107.92 $1.74 Million - $2.4 Million	-22,194 Reduced 27.4%	58,802 $4.98 Million
Q3 2018 Nov 14, 2018	SELL	$97.82 - $116.09 $29,150 - $34,594	-298 Reduced 0.37%	80,996 $7.96 Million
Q2 2018 Sep 18, 2018	SELL	$97.62 - $120.59 $281,536 - $347,781	-2,884 Reduced 3.43%	81,294 $9.4 Million
Q2 2018 Aug 14, 2018	BUY	$97.62 - $120.59 $3.14 Million - $3.87 Million	32,126 Added 61.72%	84,178 $9.74 Million
Q1 2018 May 09, 2018	BUY	$95.91 - $107.26 $104,733 - $117,127	1,092 Added 2.14%	52,052 $5.14 Million
Q4 2017 Feb 14, 2018	SELL	$104.5 - $126.38 $6.69 Million - $8.09 Million	-63,992 Reduced 55.67%	50,960 $5.34 Million
Q3 2017 Nov 13, 2017	BUY	$97.26 - $116.2 $11.2 Million - $13.4 Million	114,952	114,952 $13 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account